MEI Pharma Inc (MEIP)
3.03
-0.11
(-3.50%)
USD |
NASDAQ |
Nov 13, 16:00
3.15
+0.12
(+3.96%)
After-Hours: 20:00
MEI Pharma Cash from Financing (Quarterly): -0.208M for June 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -0.208M |
| March 31, 2024 | 0.00 |
| December 31, 2023 | -11.66M |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | -0.04M |
| June 30, 2022 | 0.02M |
| March 31, 2022 | 0.36M |
| December 31, 2021 | 48.86M |
| September 30, 2021 | -0.194M |
| June 30, 2021 | 0.067M |
| March 31, 2021 | 0.126M |
| December 31, 2020 | 0.015M |
| September 30, 2020 | 3.26M |
| June 30, 2020 | 20.83M |
| March 31, 2020 | -0.008M |
| December 31, 2019 | 48.45M |
| September 30, 2019 | 5.505M |
| June 30, 2019 | 0.273M |
| March 31, 2019 | 0.252M |
| December 31, 2018 | 0.024M |
| September 30, 2018 | 0.837M |
| June 30, 2018 | 70.02M |
| Date | Value |
|---|---|
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.169M |
| September 30, 2017 | 0.02M |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 4.212M |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | |
| June 30, 2015 | 0.00 |
| March 31, 2015 | -0.034M |
| December 31, 2014 | 43.10M |
| September 30, 2014 | |
| June 30, 2014 | -0.005M |
| March 31, 2014 | 0.001M |
| December 31, 2013 | 32.72M |
| September 30, 2013 | |
| June 30, 2013 | 14.18M |
| March 31, 2013 | -0.055M |
| December 31, 2012 | 25.33M |
| September 30, 2012 | 0.00 |
| June 30, 2012 | 4.784M |
| March 31, 2012 | 0.004M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-11.66M
Minimum
Dec 2023
48.86M
Maximum
Dec 2021
5.783M
Average
--
Median
Dec 2022
Cash from Financing (Quarterly) Benchmarks
| Avid Bioservices Inc | 0.266M |
| Evoke Pharma Inc | 0.2957M |
| Revance Therapeutics Inc | -6.087M |
| NovaBay Pharmaceuticals Inc | -0.492M |
| Palatin Technologies Inc | 5.991M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -18.00M |
| Cash from Investing (Quarterly) | 19.54M |
| Free Cash Flow | -50.48M |
| Free Cash Flow Per Share (Quarterly) | -2.701 |
| Free Cash Flow Yield | -250.0% |